Related by context. Frequent words. (Click for all words.) 65 MGCD# [002] 60 kinase inhibitor 59 humanized monoclonal antibody 59 VEGFR 58 selective inhibitor 57 Perifosine 57 small molecule inhibitor 56 hematological malignancies 56 cutaneous T cell 55 oncology indications 55 solid tumors 54 anti angiogenic 54 AP# [003] 54 potent inhibitor 54 hematologic malignancies 53 ofatumumab 53 kinase inhibitors 53 oritavancin 53 ENMD 53 XL# [003] 53 MGCD# [001] 53 HspE7 52 dose escalation study 52 TREANDA 52 hepatocellular carcinoma 52 Phase Ib 52 CUDC 52 eculizumab 52 antitumor activity 51 PF # [001] 51 ASA# 51 INCB# [002] 51 chemotherapeutic agent 51 CYT# 51 pralatrexate 51 IMGN# 50 preclinical models 50 Preclinical studies 50 anticancer agents 50 Marqibo 50 diabetic nephropathy 50 elesclomol 50 HDAC inhibitors 50 PLX# 50 5 fluorouracil 50 systemic lupus erythematosus 50 voreloxin 49 relapsing remitting multiple sclerosis 49 small molecule 49 HRPC 49 perifosine 49 dose limiting toxicities 49 mCRC 49 Alpharadin 49 tamibarotene 49 immune mediated 49 carfilzomib 49 breast ovarian 48 chronic lymphocytic leukemia CLL 48 hormone refractory prostate cancer 48 chemotherapeutic agents 48 taxane 48 factor receptor 48 dasatinib 48 taxanes 48 immunotherapies 48 bone metastases 48 NSCLC 48 HCV 48 chemotherapeutic 48 T DM1 47 acute myeloid leukemia AML 47 inflammatory diseases 47 ADVEXIN 46 cell lung cancer 46 myelofibrosis 46 CXCR4 46 metastatic melanoma 46 CD# [002] 46 gemcitabine 46 lymphomas 46 metastatic prostate cancer 46 prostate breast 46 vandetanib 46 metastatic colorectal cancer 46 clofarabine 46 FOLOTYN 46 cytotoxic 46 carcinomas 46 anti VEGF 45 monotherapy 45 GM CSF 45 sarcomas 45 hematopoietic stem cell 45 trastuzumab 45 advanced NSCLC 45 bortezomib 45 temozolomide 44 5 FU 44 malignancies 44 metastatic